Navigation Links
MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering
Date:10/5/2007

MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of common stock at a price of $12.00 per share. All shares are being offered by MAP Pharmaceuticals. In addition, MAP Pharmaceuticals has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares to cover over-allotments, if any. Merrill Lynch & Co. and Morgan Stanley & Co. Incorporated are joint book-running managers for the offering and Deutsche Bank Securities Inc. is co-lead manager for the offering. MAP Pharmaceuticals' common stock will trade on the NASDAQ Global Market under the symbol "MAPP."

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 4, 2007. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from: Merrill Lynch & Co., 4 World Financial Center, New York, New York 10080 or Morgan Stanley, Prospectus Department, 1585 Broadway, New York, New York 10036.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to their registration or qualification under the securities laws of any such state or jurisdiction.

About MAP Pharmaceuticals

Located in Mountain View, California, MAP Pharmaceuticals, Inc. uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. The Company has several proprietary product candidates in clinical development that address large market opportunities,
'/>"/>

SOURCE MAP Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... available in German . ... the naked eye, you can see which branch a bird ... of branches through the telephoto lens for high-magnification images requires ... are looking to study proteins, the active biomolecules of cells. ... for Molecular Systems Biology, and her colleagues have now come ...
(Date:5/17/2013)... PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability ,     New ... insect pressures , Syngenta unveiled ... celebration today at the company’s RTP Innovation Center. The ... allows company researchers to simulate any agricultural climate and ...
(Date:5/17/2013)... May 17, 2013  Yongye International, Inc. (NASDAQ: ... developer, manufacturer, and distributor of crop nutrient products in ... today announced that, on May 16, 2013, the special ... (the "Board of Directors") was provided a letter (the ... Kong ) Limited ("Abax") to Full Alliance International ...
(Date:5/17/2013)... FL (PRWEB) May 17, 2013 Men’s skin ... La-roche Posay ) and has been known to ... Although some men may be far from puberty, other acne ... clogging pores, causing breakouts, and threatening skin with unsightly acne ... advice from Men’s Health on how to reduce ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... opportunities noted that the FDA sees radio frequency identification ... integrity of the U.S. drug supply. RFID allows pharmaceutical ... chain of distribution from manufacturer to pharmacy. , ... an initiative to improve identification ...
... College in Eau Claire are offering up to eight ... firms or organizations with an economic interest in nanotechnology ... comprise each of five teams with project completion by ... the purchase of an electron microscope are the best ...
... Fiserv, Inc. announced strong earnings for the third ... for the third quarter of 2005 was $0.58 per share, ... 2004. Processing and services revenues were $925.3 million, an increase ... "We are also very excited about our recent acquisitions, including ...
Cached Biology Technology:RFID medical devices - Opportunities and challenges 2RFID medical devices - Opportunities and challenges 3RFID medical devices - Opportunities and challenges 4
(Date:5/18/2013)... 18, 2013) Research presented today at Digestive Disease ... with findings about the impact of coffee on autoimmune ... While coffee consumption recently has been associated with reduced ... a few more cups of java each month also ... disease. Researchers at the Mayo Clinic, Rochester, MN, linked ...
(Date:5/17/2013)... noise of the South, but the night belongs to the ... heavy from the humidity and the sounds of wildlife. ... frogs, toads and salamanders, is the center of amphibian biodiversity ... the auditorium for their symphonic choruses, the scientists of the ... have front-row seats. , Amphibians, which rely on ...
(Date:5/17/2013)... 2013, Shenzhen, China---- Why Tibetan antelope can live ... In a collaborative research published in Nature ... other institutes provide evidence that some genetic factors ... harsh highland environments. The data in this work ... mechanisms and the biology of other ruminant species. ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... all go a little gooey, but it,s not turning mums, ... Australian National University. The study conducted by the ... that despite fears mothers may have that pregnancy affects their ... true. The findings have been released as part of Mental ...
... CT Contrary to conventional wisdom, tropical plant and animal ... may be threatened by global warming, according to an article ... in this week,s (Oct. 10) issue of Science ... the geographical ranges of well-studied bird, butterfly, and plant species ...
... of patients with compromised immune systems has grown ... unique set of healthcare solutions that take into ... immune suppression to the individual patient,s nutritional status. ... of the Immunocompromised Host,examines a wide range of ...
Cached Biology News:Pregnancy not turning minds to mush: Study 2Tropical rainforest and mountain species may be threatened by global warming 2Text focuses on diagnosing infections in immunocompromised patients 2